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Background: Preoperative oral antibiotics in addition to intravenous antibiotics and mechanical bowel
preparation (MBP)may influence the gut microbiome and reduce both the postoperative systemic inflam-
matory response to surgery and postoperative infective complications following colorectal resection. This
propensity score-matched study compared outcomes of patients undergoing left-sided colonic or rectal
resection with or without a combination of oral antibiotics and MBP.
Methods: The addition of oral antibiotics and MBP to prophylactic intravenous antibiotics in left-sided
colonic and rectal resections was introduced in 2015–2016 at a single institution. Propensity score
matching was undertaken to compare the effects of oral antibiotics plus MBP versus neither oral
antibiotics nor MBP on the postoperative systemic inflammatory response and short-term outcomes in
patients undergoing left-sided colonic or rectal resection between 2013 and 2018.
Results: Of 396 patients who had propensity score matching for host, anaesthetic and operative factors,
204 matched patients were identified. The addition of oral antibiotics and MBP was associated with a
significantly reduced postoperative inflammatory response (reduced postoperative Glasgow Prognostic
Score) on day 3 (odds ratio (OR) 0⋅66, 95 per cent c.i. 0⋅44 to 0⋅99; P=0⋅013) and day 4 (OR 0⋅46, 0⋅30 to
0⋅71; P= 0⋅001). Significantly reduced overall complications (OR 0⋅31, 0⋅17 to 0⋅56; P<0⋅001), infective
complications (OR 0⋅41, 0⋅22 to 0⋅77; P=0⋅011), surgical-site infection (OR 0⋅37, 0⋅17 to 0⋅83; P=0⋅024)
and postoperative length of hospital stay (median 7days versus 8days in patients who had intravenous
antibiotics alone; P= 0⋅050) were also observed.
Conclusion: Preoperative oral antibiotics and MBP in addition to prophylactic intravenous antibiotics
were associated with a reduction in the postoperative systemic inflammatory response and postoperative
complications in patients undergoing resectional left-sided colonic or rectal surgery.
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Introduction
Approximately 1⋅8million patients are diagnosed with
colorectal cancer worldwide each year1. Resectional
surgery remains the mainstay of treatment, albeit with
significant morbidity as well as cancer-related mortality,
even after curative treatment2.
A previous Cochrane review3 reported clear evidence
for antibiotic prophylaxis versus no antibiotic prophylaxis
in the reduction of surgical-site infection (SSI) following
colorectal surgery. In that review, evidence comparing
either oral or intravenous antibiotic administration was
limited, although no significant difference was found.
When a combination of intravenous and oral antibiotic
therapy was compared with single-route administration,
a significant reduction in wound infection was reported
(risk ratio 0⋅55, P< 0⋅001). Most studies have compared
the effects of oral antibiotic administration in the context
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of mechanical bowel preparation (MBP). The effect of
oral antibiotics in addition to intravenous antibiotics in
the unprepared colon is uncertain. This is reflected in
the WHO SSI prevention guidelines4 and a recent update
to the Enhanced Recovery After Surgery (ERAS®) Soci-
ety guidelines5, both of which support the use of intra-
venous antibiotic prophylaxis immediately before surgery
in addition to oral antibiotics whenMBP is being used, but
acknowledge the need for further research into the role of
oral antibiotics without MBP.
After colorectal resection there are significant relation-
ships between increased postoperative systemic inflamma-
tory response andmore postoperativemorbidity6–8, as well
as poorer long-term oncological outcomes9–11. Measures
that modulate the systemic inflammatory response after
surgery and reduce postoperative complications are there-
fore of clinical interest.
The administration of prophylactic intravenous antibi-
otics on induction of anaesthesia is now routine, whereas
the use of preoperative oral antibiotics remains limited, as
reported in a recent European survey12 and international
audit13. Evidence, largely from the USA and Japan, has
been summarized by several meta-analyses14–17 reporting
a reduction in postoperative infective complications fol-
lowing the use of oral in addition to intravenous antibiotics.
It has been hypothesized18,19 that a local alteration in the
gut microbiome could have a significant relationship with
the host systemic inflammatory response, modifying the
risk of complications.
The primary aim of this propensity-matched study was
to examine the impact of preoperative oral antibiotics in
combination with MBP, given in addition to intravenous
antibiotics, on postoperative infective complications in
patients undergoing left-sided colonic or rectal resection.
As a secondary aim, the impact of preoperative oral antibi-
otics on the postoperative systemic inflammatory response
was examined.
Methods
This longitudinal observational study included patients
aged at least 18 years undergoing elective left-sided colonic
or rectal resection at Glasgow Royal Infirmary between
2013 and 2018. Surgery was undertaken for either benign
disease or colorectal cancer resection with curative intent.
Patients with coexisting inflammatory bowel disease or
metastatic disease, those undergoing multivisceral resec-
tions, and those undergoing emergency surgery were
excluded. All operations were performed or supervised by
a consultant colorectal surgeon.
During the time period for inclusion into this study, an
ERAS pathway was in place to standardize perioperative
care. This included: preoperative carbohydrate-loading
where appropriate; prophylactic intravenous antibiotics
at induction of anaesthesia; venous thromboprophylaxis;
early enteral nutrition; early mobilization; and avoidance
of routine peritoneal or nasogastric drainage. The use of
perioperative dexamethasone to reduce the risk of postop-
erative nausea and vomiting, and regional anaesthetic tech-
nique was at the discretion of the surgical and anaesthetic
teams caring for the patient.
Preoperative oral antibiotics and MBP were introduced
in 2015, but their use was not widespread until 2016.
Before 2015–2016, and therefore in the control group,
neither oral antibiotics nor MBP were in routine use.
Instead, patients undergoing rectal surgery were given a
single phosphate enema, whereas those having a left-sided
colonic resection received no bowel preparation. Patients
in the treatment group were treated predominantly in
2016–2018, and received preoperative oral antibiotics in
the form of neomycin (1 g) and metronidazole (400mg) at
15⋅00, 16⋅00 and 22⋅00 hours on the day before surgery,
and oral MBP in the form of four sachets of Klean-Prep®
(Norgine, Harefield, UK), a macrogol-based laxative. All
patients received prophylactic intravenous antibiotics on
induction of anaesthesia regardless of whether they were
in the control group, predominantly from 2013 to 2016,
or the treatment group, predominantly from 2016 to
2018.
Patients were assessed clinically every day after surgery
with blood analysis, including estimation of C-reactive
protein (CRP) on most postoperative days. Other inves-
tigations and interventions for clinical or biochemical
concerns were carried out at the discretion of the team
caring for the patient.
Clinicopathological data were collected in a secure,
prospectively collated, electronic database in line with
local NHS Greater Glasgow and Clyde policy, which
detailed whether or not patients received oral antibiotics
and MBP. Additional data, including laboratory results,
clinical letters, inpatient records and operation notes, were
obtained from online patient records.
Clinicopathological data collected included: site of
surgery (left-sided, rectal without perineal incision, rec-
tal with perineal incision); presence of diabetes; use of
perioperative dexamethasone; use of regional anaesthesia;
surgical approach (laparoscopic or open); duration of
surgery; need for intraoperative blood transfusion; and
the preoperative inflammatory state using the modified
Glasgow Prognostic Score (mGPS)20.
Outcomes of interest were postoperative complications,
the postoperative inflammatory response, and postopera-
tive length of hospital stay.
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Complications were categorized as overall complications,
infective complications and non-infective complications.
Infective complications were subcategorized as non-SSI
or SSIs, which were then further subcategorized as fol-
lows: superficial SSI (presence of pus either discharg-
ing spontaneously or requiring drainage or the use of
antibiotics due to a diagnosis of cellulitis around the
wound); deep SSI (intra-abdominal pus or infection requir-
ing either drainage or antibiotic therapy); or anastomotic
leakage (diagnosed either on imaging or at laparotomy).
Complications were categorized by severity using the
Clavien–Dindo classification21.
A CRP threshold above 150mg/l and an albumin level
below 25mg/l on day 3 and 4 was recorded. A postoper-
ative Glasgow Prognostic Score (poGPS)8 was calculated
for patients for whom CRP and albumin results were avail-
able. Postoperative mortality was defined as death within
30 days of surgery. Length of hospital stay was defined as
the median number of days between surgery and hospital
discharge.
This study was approved by NHS Greater Glasgow and
Clyde Information Governance Unit and the Caldicott
Guardian as part of surgical audit. Data were collected
by clinical research fellows, with discussion with a senior
author when appropriate. Those collecting data had access
to the database and online patient records.
Statistical analysis
In the unmatched cohort, categorical data were compared
using the χ2 test. Data on postoperative length of stay were
non-parametric and are presented asmedian (range) values.
Medians were compared using an independent-samples
median test. A two-sided P< 0⋅050 was considered signif-
icant. Measurement of association between variables for
both unmatched and matched data was carried out using
either the φ coefficient or Cramer’s V test (φc). All statisti-
cal analyses were carried out using IBM SPSS® version 24
for Windows® (IBM, Armonk, New York, USA).
Patients were propensity score matched for age, sex, site
of surgery, surgical approach, BMI, ASA grade, smoking
status, preoperative mGPS, intraoperative blood transfu-
sion, stoma formation, coexisting diabetes, use of regional
anaesthesia, and use of preoperative dexamethasone. Each
patient who received preoperative oral antibiotics was
matched 1 : 1 with a patient who did not, using the closest
propensity score on the logit scale (calliper less than 0⋅05,
order of match selection randomized, without replace-
ment). The appropriateness of propensity score matching
was assessed visually by the frequency of propensity scores
in each group before and after matching. Propensity scores
Fig. 1 Flow diagram of antibiotic administration before and
after propensity score matching
Elective colorectal resections n=396
 No antibiotics n=227
 Antibiotics plus MBP n=169
Propensity score assigned n=243
 No antibiotics n=102
 Antibiotics plus MBP n=141
Matched n=204
 No antibiotics n=102
 Antibiotics plus MBP n=102
Propensity score not assigned
 (missing data) n=153
 No antibiotics n=125
 Antibiotics plus MBP n=28
Unmatched n=39 
MBP, mechanical bowel preparation.
were calculated only for patients who did not have missing
data in the variables used in the propensity scoring process.
Within the propensity score-matched data, McNemar’s
test was used to compare categorical data when this was in
a 2× 2 table or using a McNemar–Bowker test22 when the
data table was more than 2× 2. Binary logistic regression
was used to calculate odds ratios (ORs) and 95 per cent c.i.
for outcomes within the propensity score-matched data set.
The treatment effect of preoperative oral antibiotics and
MBP in terms of poGPS on day 3 after surgery, over-
all complications and overall infective complications was
displayed as ORs with 95 per cent c.i. for unmatched
and matched patients. In addition, propensity scores were
included along with preoperative oral antibiotics and MBP
as a linear co-variable in multivariable binary logistic
regression for day 3 poGPS, overall complications and
infective complications.
Results
A total of 396 patients were included in this study, of
whom 227 (57⋅3 per cent) did not and 169 (42⋅7 per cent)
did receive preoperative oral antibiotics (Fig. 1). Some 223
patients (56⋅3 per cent) were men, and 131 (33⋅1 per cent)
were aged over 65 years. Most had rectal (266 patients,
67⋅2 per cent) and malignant (90⋅6 per cent) disease.
Laparoscopic resections were carried out in 192 patients
(48⋅5 per cent), with the remainder having open surgery.
Patient characteristics for the entire cohort are shown
in Table 1. There were significant differences between the
group of patients who received preoperative oral antibiotics
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Table 1 Association between clinicopathological characteristics, perioperative factors and oral antibiotic administration in patients
undergoing left-sided colonic or rectal surgery, before propensity score matching
Total
(n=396)
No oral antibiotics
(n=227)
Oral antibiotics
(n=169) φ/Cramer’s V P*
Age (years) 0⋅124 0⋅048
<65 183 (46⋅2) 93 (41⋅0) 90 (53⋅3)
65–74 131 (33⋅1) 84 (37⋅0) 47 (27⋅8)
≥75 82 (20⋅7) 50 (22⋅0) 32 (18⋅9)
Sex −0⋅012 0⋅811
M 223 (56⋅3) 129 (56⋅8) 94 (55⋅6)
F 173 (43⋅7) 98 (43⋅2) 75 (44⋅4)
Site of surgery 0⋅199 <0⋅001
Left colon 130 (32⋅8) 65 (28⋅6) 65 (38⋅5)
Rectal (without perineal incision) 219 (55⋅3) 123 (54⋅2) 96 (56⋅8)
Rectal (with perineal incision) 47 (11⋅9) 39 (17⋅2) 8 (4⋅7)
Benign or malignant n=395 n=226 −0⋅372 <0⋅001
Benign 37 (9⋅4) 0 (0) 37 (21⋅9)
Malignant 358 (90⋅6) 226 (100) 132 (78⋅1)
Laparoscopic or open 0⋅082 0⋅101
Laparoscopic 192 (48⋅5) 102 (44⋅9) 90 (53⋅3)
Open 204 (51⋅5) 125 (55⋅1) 79 (46⋅7)
BMI (kg/m2) n=395 n=226 0⋅118 0⋅137
<20 13 (3⋅3) 8 (3⋅5) 5 (3⋅0)
20–25 137 (34⋅7) 86 (38⋅1) 51 (30⋅2)
26–30 137 (34⋅7) 80 (35⋅4) 57 (33⋅7)
>30 108 (27⋅3) 52 (23⋅0) 56 (33⋅1)
ASA grade n=384 n=224 n=160 0⋅217 <0⋅001
I 99 (25⋅8) 73 (32⋅6) 26 (16⋅3)
II 184 (47⋅9) 104 (46⋅4) 80 (50⋅0)
III 96 (25⋅0) 43 (19⋅2) 53 (33⋅1)
IV 5 (1⋅3) 4 (1⋅8) 1 (0⋅6)
Smoking status n=395 n=226 0⋅141 0⋅020
Never 187 (47⋅3) 109 (48⋅2) 78 (46⋅2)
Ex-smoker 140 (35⋅4) 88 (38⋅9) 52 (30⋅8)
Smoker 68 (17⋅2) 29 (12⋅8) 39 (23⋅1)
Diabetes n=395 0⋅023 0⋅649
No 347 (87⋅8) 200 (88⋅5) 147 (87⋅0)
Yes 48 (12⋅2) 26 (11⋅5) 22 (13⋅0)
Preoperative mGPS n=367 n=216 n=151 0⋅131 0⋅043
0 302 (82⋅3) 176 (81⋅5) 126 (83⋅4)
1 29 (7⋅9) 13 (6⋅0) 16 (10⋅6)
2 36 (9⋅8) 27 (12⋅5) 9 (6⋅0)
Intraoperative transfusion n=385 n=217 n=168 −0⋅135 0⋅008
No 372 (96⋅6) 205 (94⋅5) 167 (99⋅4)
Yes 13 (3⋅4) 12 (5⋅5) 1 (0⋅6)
Stoma −0⋅132 0⋅009
No 204 (51⋅5) 104 (45⋅8) 100 (59⋅2)
Yes 192 (48⋅5) 123 (54⋅2) 69 (40⋅8)
Duration of surgery >4h n=391 n=225 n=166 0⋅077 0⋅128
No 132 (33⋅8) 83 (36⋅9) 49 (29⋅5)
Yes 259 (66⋅2) 142 (63⋅1) 117 (70⋅5)
Other anaesthesia n=377 n=211 n=166 0⋅391 <0⋅001
None 85 (22⋅5) 47 (22⋅3) 38 (22⋅9)
Spinal 144 (38⋅2) 49 (23⋅2) 95 (57⋅2)
Epidural 98 (26⋅0) 79 (37⋅4) 19 (11⋅4)
Other 50 (13⋅3) 36 (17⋅1) 14 (8⋅4)
Dexamethasone n=382 n=215 n=167 0⋅109 0⋅033
No 96 (25⋅1) 63 (29⋅3) 33 (19⋅8)
Yes 286 (74⋅9) 152 (70⋅7) 134 (80⋅2)
Values in parentheses are percentages. mGPS, modified Glasgow Prognostic Score. *χ2 test.
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Fig. 2 Distribution of propensity scores before and after matching
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and MBP and those who did not for age (φc = 0⋅124,
P= 0⋅048), site of surgery (φc = 0⋅199, P< 0⋅001), pro-
portion of malignant disease (φ=−0⋅372, P< 0⋅001),
ASA grade (φc = 0⋅217, P< 0⋅001), smoking history
(φc = 0⋅141, P= 0⋅020), preoperative mGPS (φc = 0⋅131,
P= 0⋅043), need for intraoperative blood transfusion
(φ=−0⋅135, P= 0⋅008), proportion of patients with a
stoma (φ=−0⋅132, P= 0⋅009) and the use of regional
anaesthesia (φc = 0⋅391, P< 0⋅001) or dexamethasone
(φ= 0⋅109, P= 0⋅033).
Propensity score-matched patients
It was not possible to assign propensity scores to 153
patients because of missing co-variable data; thus, propen-
sity scores were assigned to 243 patients, 102 of whom did
not and 141 of whom did receive preoperative oral antibi-
otics. Overall, 204 patients (102 from each group) were
matched based on their propensity score (Fig. 1). There was
subsequent improvement in the balance of the distribution
of propensity scores in each group on visual representation
(Fig. 2), and improvement in the φ coefficient/Cramer’s φ
(φc), as shown in Table 2.
In the matched cohort, a significantly smaller proportion
of patients who received oral antibiotics had a CRP level
of 150mg/l or above on postoperative day (POD) 4 (17 per
cent versus 40 per cent in those who did not; P< 0⋅001), but
not on POD3 (35 versus 42 per cent respectively;P= 0⋅154)
(Table 3). Significantly more patients receiving oral antibi-
otics had a postoperative albumin concentration of 25mg/l
or more on POD3 (84 versus 67 per cent respectively;
P= 0⋅003) and POD4 (78 versus 56 per cent; P= 0⋅011)
compared with those who did not. Correspondingly, sig-
nificantly fewer patients receiving oral antibiotics had a
poGPS greater than 0 on POD3 (34 versus 43 per cent;
P= 0⋅013) and POD4 (17 versus 40 per cent; P= 0⋅001).
Corresponding ORs are shown in Table 3.
A significant reduction in overall complications was
observed in the group receiving preoperative oral antibi-
otics (27⋅5 per cent versus 55⋅9 per cent in patients not
receiving oral antibiotics; P< 0⋅001). Preoperative oral
antibiotics were associated with a significant reduction in
the rate of infective complications (19⋅6 versus 37⋅3 per
cent respectively; P= 0⋅011) and overall SSI (9⋅8 versus 22⋅5
per cent; P= 0⋅024). A significant reduction was seen in
overall Clavien–Dindo complication grade (P= 0⋅007) and
postoperative length of stay (7 versus 8 days; P= 0⋅050) in
those receiving preoperative oral antibiotics. No signifi-
cant difference was seen with the use of preoperative oral
antibiotics and MBP in the rate of deep SSI (2⋅9 versus
6⋅9 per cent; P= 0⋅344), superficial SSI (2⋅9 versus 10⋅8 per
cent; P= 0⋅057), anastomotic leak (3⋅9 versus 7⋅8 per cent;
P= 0⋅388) or non-SSI (9⋅8 versus 14⋅7 per cent; P= 0⋅405).
Corresponding ORs are shown in Table 3.
Sensitivity analysis of the impact of oral antibiotics and
MBP on rates of increased poGPS on POD3 found a
similar statistically significant probability reduction using
regression adjustment (OR 0⋅73, 95 per cent c.i. 0⋅50 to
1⋅06) and propensity score matching (OR 0⋅66, 0⋅44 to
0⋅99). Similar results were seen for overall complications
using regression adjustment (OR 0⋅39, 0⋅23 to 0⋅66)
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Table 2 Association between clinicopathological characteristics, perioperative factors and oral antibiotic administration in patients
undergoing left-sided colonic or rectal surgery, after propensity score matching
Variable
matched for
Total
(n=204)
No oral antibiotics
(n=102)
Oral antibiotics
(n=102) φ/Cramer’s V
Age (years) Yes 0⋅114
<65 91 (44⋅6) 44 (43⋅1) 47 (46⋅1)
65–74 70 (34⋅3) 40 (39⋅2) 30 (29⋅4)
≥75 43 (21⋅1) 18 (17⋅6) 25 (24⋅5)
Sex Yes −0⋅010
M 115 (56⋅4) 58 (56⋅9) 57 (55⋅9)
F 89 (43⋅6) 44 (43⋅1) 45 (44⋅1)
Site of surgery Yes 0⋅119
Left colon 64 (31⋅4) 34 (33⋅3) 30 (29⋅4)
Rectal (without perineal incision) 120 (58⋅8) 55 (53⋅9) 65 (63⋅7)
Rectal (with perineal incision) 20 (9⋅8) 13 (12⋅7) 7 (6⋅9)
Benign or malignant No 0⋅271
Benign 14 (6⋅9) 0 (0) 14 (13⋅7)
Malignant 190 (93⋅1) 102 (100) 88 (86⋅3)
Laparoscopic or open Yes 0⋅010
Laparoscopic 111 (54⋅4) 55 (53⋅9) 56 (54⋅9)
Open 93 (45⋅6) 47 (46⋅1) 46 (45⋅1)
BMI (kg/m2) Yes 0⋅038
<20 4 (2⋅0) 2 (2⋅0) 2 (2⋅0)
20–25 73 (35⋅8) 38 (37⋅3) 35 (34⋅3)
26–30 72 (35⋅3) 36 (35⋅3) 36 (35⋅3)
>30 55 (27⋅0) 26 (25⋅5) 29 (28⋅4)
ASA grade Yes 0⋅077
I 47 (23⋅0) 25 (24⋅5) 22 (21⋅6)
II 98 (48⋅0) 50 (49⋅0) 48 (47⋅1)
III 56 (27⋅5) 25 (24⋅5) 31 (30⋅4)
IV 3 (1⋅5) 2 (2⋅0) 1 (1⋅0)
Smoking status Yes 0⋅144
Never 91 (44⋅6) 43 (42⋅2) 48 (47⋅1)
Ex-smoker 75 (36⋅8) 44 (43⋅1) 31 (30⋅4)
Smoker 38 (18⋅6) 15 (14⋅7) 23 (22⋅5)
Diabetes Yes 0⋅032
No 182 (89⋅2) 92 (90⋅2) 90 (88⋅2)
Yes 22 (10⋅8) 10 (9⋅8) 12 (11⋅8)
Preoperative mGPS Yes 0⋅018
0 175 (85⋅8) 88 (86⋅3) 87 (85⋅3)
1 17 (8⋅3) 8 (7⋅8) 9 (8⋅8)
2 12 (5⋅9) 6 (5⋅9) 6 (5⋅9)
Intraoperative transfusion Yes 0⋅000
No 202 (99⋅0) 101 (99⋅0) 101 (99⋅0)
Yes 2 (1⋅0) 1 (1⋅0) 1 (1⋅0)
Duration of surgery >4h Yes 0⋅021
No 62 (30⋅4) 30 (29⋅4) 32 (31⋅4)
Yes 142 (69⋅6) 72 (70⋅6) 70 (68⋅6)
Stoma Yes 0⋅020
No 112 (54⋅9) 57 (55⋅9) 55 (53⋅9)
Yes 92 (45⋅1) 45 (44⋅1) 47 (46⋅1)
Other anaesthesia Yes 0⋅300
None 60 (29⋅4) 39 (38⋅2) 21 (20⋅6)
Spinal 86 (42⋅2) 28 (27⋅5) 58 (56⋅9)
Epidural 35 (17⋅2) 21 (20⋅6) 14 (13⋅7)
Other 23 (11⋅3) 14 (13⋅7) 9 (8⋅8)
Dexamethasone Yes −0⋅038
No 37 (18⋅1) 17 (16⋅7) 20 (19⋅6)
Yes 167 (81⋅9) 85 (83⋅3) 82 (80⋅4)
Values in parentheses are percentages. mGPS, modified Glasgow Prognostic Score.
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Table 3 Patient outcomes within the propensity score-matched cohort
Total
(n=204)
No oral
antibiotics + MBP
(n=102)
Oral
antibiotics + MBP
(n=102) Odds ratio† P
CRP≥ 150 (mg/l) (POD3) n=193 n=95 n=98 0⋅73 (0⋅41, 1⋅31) 0⋅154
No 119 (61⋅7) 55 (58) 64 (65)
Yes 74 (38⋅3) 40 (42) 34 (35)
CRP≥ 150 (mg/l) (POD4) n=166 n=78 n=88 0⋅31 (0⋅15, 0⋅64) <0⋅001
No 120 (72⋅3) 47 (60) 73 (83)
Yes 46 (27⋅7) 31 (40) 15 (17)
Albumin ≥25 (mg/l) (POD3) n=190 n=94 n=96 2⋅66 (1⋅32, 5⋅35) 0⋅003
No 46 (24⋅2) 31 (33) 15 (16)
Yes 144 (75⋅8) 63 (67) 81 (84)
Albumin ≥25 (mg/l) (POD4) n=167 n=78 n=89 2⋅67 (1⋅37, 5⋅21) 0⋅011
No 54 (32⋅3) 34 (44) 20 (22)
Yes 113 (67⋅7) 44 (56) 69 (78)
poGPS (POD3) n=190 n=94 n=96 0⋅66 (0⋅44, 0⋅99) 0⋅013
0 117 (61⋅6) 54 (57) 63 (66)
1 47 (24⋅7) 21 (22) 26 (27)
2 26 (13⋅7) 19 (20) 7 (7)
poGPS (POD4) n=166 n=78 n=88 0⋅46 (0⋅30, 0⋅71) 0⋅001
0 120 (72⋅3) 47 (60) 73 (83)
1 16 (9⋅6) 8 (10) 8 (9)
2 30 (18⋅1) 23 (29) 7 (8)
Any complication 0⋅31 (0⋅17, 0⋅56) <0⋅001
No 120 (58⋅8) 46 (45⋅1) 74 (72⋅5)
Yes 84 (41⋅2) 56 (54⋅9) 28 (27⋅5)
Infective complication 0⋅41 (0⋅22, 0⋅77) 0⋅011
No 146 (71⋅6) 64 (62⋅7) 82 (80⋅4)
Yes 58 (28⋅4) 38 (37⋅3) 20 (19⋅6)
SSI 0⋅37 (0⋅17, 0⋅83) 0⋅024
No 171 (83,8) 79 (77⋅5) 92 (90⋅2)
Yes 33 (16⋅2) 23 (22⋅5) 10 (9⋅8)
Deep SSI 0⋅41 (0⋅10, 1⋅64) 0⋅344
No 194 (95⋅1) 95 (93⋅1) 99 (97⋅1)
Yes 10 (4⋅9) 7 (6⋅9) 3 (2⋅9)
Superficial SSI 0⋅25 (0⋅07, 0⋅93) 0⋅057
No 190 (93⋅1) 91 (89⋅2) 99 (97⋅1)
Yes 14 (6⋅9) 11 (10⋅8) 3 (2⋅9)
Anastomotic leak 0⋅48 (0⋅14, 1⋅65) 0⋅388
No 192 (94⋅1) 94 (92⋅2) 98 (96⋅1)
Yes 12 (5⋅9) 8 (7⋅8) 4 (3⋅9)
Non-SSI infection 0⋅63 (0⋅27, 1⋅48) 0⋅405
No 179 (87⋅7) 87 (85⋅3) 92 (90⋅2)
Yes 25 (12⋅3) 15 (14⋅7) 10 (9⋅8)
Clavien–Dindo complication grade 0⋅51 (0⋅33, 0⋅80) 0⋅007
0 123 (60⋅3) 49 (48⋅0) 74 (72⋅5)
I–II 61 (29⋅9) 41 (40⋅2) 20 (19⋅6)
III–V 20 (9⋅8) 12 (11⋅8) 8 (7⋅8)
Postoperative death –
No 201 (98⋅5) 99 (97⋅1) 102 (100)
Yes 3 (1⋅5) 3 (2⋅9) 0 (0)
Postoperative length of stay (days)* 8 (2–122) 7 (2–69) – 0⋅050
Values in parentheses are percentages unless indicated otherwise; *values are median (range); †values in parentheses are 95 per cent confidence intervals.
MBP, mechanical bowel preparation; POD, postoperative day; poGPS, postoperative Glasgow Prognostic Score; SSI, surgical-site infection.
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Table 4 Odds ratios for increasing postoperative Glasgow Prognostic Score on day 3, overall and infective complications with respect
to use of preoperative oral antibiotics and mechanical bowel preparation across the propensity score methods
Odds ratio
No. of patients Day3 poGPS Overall complications Infective complications
Propensity score model
Unadjusted 396 0⋅60 (0⋅45, 0⋅80) 0⋅50 (0⋅33, 0⋅75) 0⋅60 (0⋅39, 0⋅94)
PS regression 243 0⋅73 (0⋅50, 1⋅06) 0⋅39 (0⋅23, 0⋅66) 0⋅48 (0⋅27, 0⋅86)
Matched 204 0⋅66 (0⋅44, 0⋅99) 0⋅31 (0⋅17, 0⋅56) 0⋅41 (0⋅22, 0⋅77)
Values in parentheses are 95 per cent confidence intervals. poGPS, postoperative Glasgow Prognostic Score; PS, propensity score.
and propensity score matching (OR 0⋅31, 0⋅17 to
0⋅56), as well as for infective complications: OR 0⋅48
(0⋅27 to 0⋅86) and OR 0⋅41 (0⋅22 to 0⋅77) respectively
(Table 4).
Discussion
The addition of preoperative oral antibiotics in combi-
nation with MBP to standard ERAS care (including pro-
phylactic intravenous antibiotics) was associated with sig-
nificantly reduced postoperative systemic inflammatory
response, infective complications and length of hospital
stay in patients undergoing left-sided colonic or rectal
resection. Within the matched cohort there was a reduced
poGPS on POD3 and 4, and significantly fewer over-
all complications, overall infective complications, overall
SSIs and superficial SSIs. The addition of oral antibiotics
improved patient outcomes.
This study complements existing literature supporting
the beneficial effect of oral antibiotics in addition to intra-
venous antibiotics and MBP in reducing postoperative
systemic inflammation and complications after left-sided
colonic and rectal resections. This includes a recent inter-
national multicentre audit13 reporting a reduction in anas-
tomotic leaks with a combination of preoperative oral
antibiotics and MBP, and a recent meta-analysis15 suggest-
ing a significant beneficial effect of addition of oral antibi-
otics to MBP in reducing overall morbidity and mortality,
including SSI and anastomotic leak.
The level 1 evidence for preoperative oral antibiotics is
limited to a number of relatively small, often historical,
trials, as summarized in several recent meta-analyses14,15,23.
Many of these trials compared oral antibiotics with no
oral antibiotics only in patients receiving MBP. Thus it
was not clear whether additional beneficial effects from
oral antibiotics would be seen in patients without MBP.
The addition of oral antibiotics in patients receiving MBP
has, however, now been incorporated into the most recent
ERAS® update5.
Although not specifically analysed in the present study,
the combination of oral antibiotics and MBP was both tol-
erable and acceptable to patients. Current literature reports
minimal adverse events with this intervention. One RCT24
reported increased nausea and vomiting in patients receiv-
ing three preoperative doses of oral antibiotics compared
with that in patients receiving either one dose or no antibi-
otics (P< 0⋅001), although other trials25–29 have reported
no negative effects of additional oral antibiotics in terms
of enteritis, colitis and/or diarrhoea, including Clostridium
difficile infection.
A heightened postoperative systemic inflammatory
response is associated with both increased postoperative
complications and worse long-term outcomes, including
an increased rate of cancer recurrence, poorer survival
and decreased quality of life11,30–32. Reducing both the
postoperative systemic inflammatory response and post-
operative complications is important in improving both
short- and long-term outcomes for the patients, in addition
to economic benefits.
The present study has a number of limitations. Propen-
sity score matching to minimize selection bias resulted in
the exclusion of a substantial proportion of patients ini-
tially included in the study. Although the cohort that did
not receive oral antibiotics included only patients under-
going resection for malignant pathology, the group that
did receive oral antibiotics and MBP additionally included
a small proportion of patients who had a resection for
benign pathology. The present analysis did not propen-
sity score match for this variation. It seems unlikely that
this discrepancy would have had a significant effect on
short-term outcomes. There was no statistically significant
reduction in deep SSI or anastomotic leak rates, as reported
in some larger studies29. It seems likely that this reflected
relatively low rates of these complications that this study
was not powered to detect. The longitudinal nature of the
study may have introduced bias between groups owing to
changes in anaesthetic/surgical technique over the time
period included, but no major alterations to surgical or
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anaesthetic technique, other than the introduction of oral
antibiotics and MBP, were apparent. Dexamethasone and
regional anaesthesia use were included within propensity
score matching to minimize the potential for bias due to
these interventions.
The addition of preoperative antibiotics and MBP to
standard perioperative care resulted in significant reduc-
tion in the postoperative systemic inflammatory response,
postoperative morbidity and postoperative length of stay
in patients undergoing elective left-sided colonic or rectal
resection. This strategy is worthy of further investigation
and potentially wider adoption.
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